The effects of the COVID-19 pandemic on patients with lysosomal storage disorders in Israel.

Eyal KristalBen Pode-ShakkedGuy HazanEhud BanneGalina LingOdeya DavidEilon ShanyAnnick Raas-RothschildYair AniksterKatya KnellerEli HershkovitzYuval E LandauRonen SpiegelYoav ZehaviOrna Staretz-Chacham

Published in: Orphanet journal of rare diseases (2021)

We observed high rates of treatment adherence and low morbidity through the COVID-19 pandemic in patients with LSDs in Israel. LSDs patients can be a model for patients with complex chronic diseases requiring routine treatments and surveillance during a pandemic or other disruption of daily routine.

Keyphrases

end stage renal disease
clinical practice
ejection fraction
newly diagnosed
sars cov
coronavirus disease
chronic kidney disease
public health
prognostic factors
physical activity
patient reported outcomes
adipose tissue
smoking cessation